NEWS: Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

@oxfordoncology.bsky.social will lead the programme alongside GSK uniting four University departments, and Oxford’s exceptional record in vaccine development.

https://www.medsci.ox.ac.uk/news/oxford-and-gsk-launch-ps50million-immuno-prevention-programme-to-advance-novel-cancer-research